[1] Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol, 2017, 67: 862-873. [2] Li J, Zou B, Yeo Y H, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2019, 4: 389-398. [3] Sheka AC, Adeyi O, Thompson J, et al. Nonalcoholic steatohepatitis: a review. JAMA, 2020, 323: 1175-1183. [4] Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med, 2017, 377: 2063-2072. [5] Kanwal F, Kramer JR, Mapakshi S, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology, 2018, 155: 1828-1837 e2. [6] Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol, 2020, 73: 202-209. [7] Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int, 2020, 14: 889-919. [8] 别宁凡.2015-2017年广西某高校学生体检脂肪肝情况分析.临床合理用药杂志,2019,12:137-138. [9] 焦亚英.我院学生体检B超脂肪肝资料分析.内蒙古医学杂志,2008:104-105. [10] 李俊峰.大学生健康体检脂肪肝临床资料分析.中国卫生产业,2015,12:10-12. [11] Asso M, Beaugrand M, De Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol, 2010, 36: 1825-1835. [12] Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol, 2017, 66: 1022-1030. [13] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版).中华肝脏病杂志,2010(03):163-166. [14] Arts FJ, Kuipers H, Jeukendrup AE, et al. A short cycle ergometer test to predict maximal workload and maximal oxygen uptake. Int J Sports Med, 1993, 14: 460-464. [15] Heydari P, Varmazyar S, Variani AS, et al. Correlation of Gerkin, Queen's College, George, and Jackson methods in estimating maximal oxygen consumption. Electron Physician, 2017, 9: 5525-5530. [16] 中华医学会健康管理学分会, 中国营养学会, 中国医疗保健国际交流促进会生殖医学分会. 超重或肥胖人群体重管理专家共识及团体标准. 中华健康管理学杂志,2018, 12: 200-207. [17] Bailey RL, Miller PE, Mitchell DC, et al. Dietary screening tool identifies nutritional risk in older adults. Am J Clin Nutr, 2009, 90: 177-183. [18] Abeysekera KWM, Fernandes GS, Hammerton G, et al. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. Lancet Gastroenterol Hepatol, 2020, 5: 295-305. [19] 薛芮,范建高.代谢相关脂肪性肝病新定义的国际专家共识简介.临床肝胆病杂志,2020,36(6):1224-1227. |